[CAS NO. 846557-71-9]  ML385

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [846557-71-9]

Catelog
SLK-S8790
Brand
Selleck
CAS
846557-71-9

DESCRIPTION [846557-71-9]

Overview

MDL-
Molecular Weight511.59
Molecular FormulaC29H25N3O4S
SMILESO=C(NC1=NC(C2=CC=C(N(C(C3=C(C)C=CC=C3)=O)CC4)C4=C2)=C(C)S1)CC5=CC(OCO6)=C6C=C5

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.9547 mL9.7735 mL19.5469 mL
5 mM0.3909 mL1.9547 mL3.9094 mL
10 mM0.1955 mL0.9773 mL1.9547 mL
50 mM---

Description

ML385 is a novel and specific inhibitor with an IC50 of 1.9 μM. It inhibits the downstream target gene expression of NRF2. NRF2 regulates the activity of several and lipid peroxidation-related proteins.

Targets

Ferroptosis [3]Nrf2 [1]
1.9 μM

In vitro

ML385 shows anti-tumor activity in NSCLC (subcutaneous and orthotopic NSCLC models) both as a single agent and in combination with carboplatin. The PK profile tested in CD-1 mice shows that ML385 has a half-life (t = 2.82 h) after IP injection (30 mg/kg). ML385 could alleviate the pancreatic injury.